Kailos Genetics, based in Huntsville, AL, announced on July 11 a strategic partnership with and investment from In-Q-Tel, Inc. (IQT). IQT is the non-profit strategic investor that identifies and accelerates the development of innovative technologies to support the mission of the U.S. Intelligence Community.
This strategic partnership and investment allows Kailos to continue the development of NGS laboratory and software solutions that may benefit the intelligence community.
“Kailos Genetics’ combination of genomic technologies represents an approach that is unique in the marketplace,” said Tom Gillespie, investment partner at IQT. “We believe that further development of this technology will provide valuable capabilities for both the public and private sector.”
“We’re excited to partner with IQT to continue our development of solutions for the identification of genetic materials,” said Troy Moore, chief scientific officer of Kailos Genetics. “This partnership will foster positive outcomes for the intelligence community.”